Nexalin Technology

Nexalin Technology Equity Turnover

The Equity Turnover of Nexalin Technology (NXL) as of Oct 18, 2026 is 0.08. In the previous year, Equity Turnover was 0.05 — a change of 75.35% (higher).

Equity Turnover

0.08

YoY

75.35%

Last updated:

Equity Turnover of Nexalin Technology is 2025 0.08 . Equity Turnover of Nexalin Technology was 2024 0.05 . It decreases by 75.35% higher compared to the previous year.

The Nexalin Technology Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2019
-0.18 USD
Jan 1, 2020
-0.15 USD
Jan 1, 2021
-0.09 USD
Jan 1, 2022
0.24 USD
Jan 1, 2023
0.03 USD
Jan 1, 2024
0.05 USD
Jan 1, 2025
0.08 USD
The Nexalin Technology Equity Turnover history
YEAREquity TurnoverYoY
0.08+75.35%
0.05+32.89%
0.03-85.68%
0.24-381.58%
-0.09-43.92%
-0.15-13.14%
-0.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nexalin Technology Stock analysis

What does Nexalin Technology do? Nexalin Technology Inc, headquartered in Laguna Niguel, California, designs and develops neurostimulation products within the US health care sector. Listed on September 16, 2022, the company employs six full-time staff members. Its flagship device, Generation 1, utilizes bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The non-invasive system applies a high-frequency, charge-balanced electrical current waveform via head electrodes, offering relief without adverse side effects. Additionally, Nexalin is designing clinical trials for Generation 2, targeting substance use disorders, particularly opiate abuse, as well as chronic pain, Alzheimer’s disease, and dementia. These devices operate using varying voltages and frequencies to address mental health issues effectively. Nexalin Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nexalin Technology stock

Equity Turnover of Nexalin Technology is 0.08 in 2025.

Equity Turnover of Nexalin Technology changed from 0.05 to 0.08, representing a 75.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Nexalin Technology since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Nexalin Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Nexalin Technology

All Key Metrics — Nexalin Technology